throbber
November 1998
`
`Chem. Pharm. Bull, 46(1 l) 1797--1802 (1998)
`
`1797
`
`Enhancing Effect of N-Acetyl-L-cysteine or 2-Mercaptoethanol on the in
`Vitro Permeation of 5-Fluorouracil or Tolnaftate through the Human Nail
`Plate
`
`Yoichi KOBAYASHIa, Misao MIYAMOTOb, Kenji SUG1BAYASHIa and Yasunori MORIMOTO*’a
`
`Faculty of PharmaceuticaI Sciences, dosai University,’~ 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan and Nissan
`Chemical Co., Ltd./’ 3 7-1 Kanda-Nishiki-cho, Chiyoda-ku, To~o 10l 0054, Japan.
`Received June 1, 1998; accepted August 5, 1998
`
`The enhancing effects of various vehicles on the in vitro permeation of a hydrophilic model drug, 5-fluo-
`rouracil (5-FU), or a lipophilic model drug, tolnaftate (TN), through human nail plates were investigated using a
`modified side-by-side diffusion cell. Tip pieces from the 5th finger-nail, clipped from healthy volunteers, were
`used in this permeation study. The swelling and softening properties of the nail pieces were also measured in
`each vehicle. The weights and stresses of the nail pieces were dramatically changed after immersion in aqueous
`solvents containing N-acetyl-L-cysteine (AC) or 2-mercaptoethanol (ME). However, no significant change in the
`physicochemical properties of the nail pieces was found in the lipophilic vehicles. Thus, the water content in the
`nail plates absorbed from vehicles may relate to their physicochemical properties. Although keratin-softening
`agents and new skin permeation enhancers did not significantly promote 5-FU permeation compared with water
`alone, the flux from solvent systems containing AC or ME was substantially higher. In addition, TN permeation
`from solvents containing AC or ME could be measured, whereas that from other solvents was undetectable.
`When the AC concentration was increased, the 5-FU permeation and the nail weight increased and the stress of
`each nail piece decreased. It is concluded from these experimental results that AC and ME may be useful as en-
`hancers for increasing drug permeation through the human nail plate.
`
`Key words nail; nail permeation; permeation enhancer; acetylcysteine; mereaptoethanol; 5-fluorouracit; tolnaftate
`
`Recent research on fungal diseases has produced a variety
`of new antifungal agents, having a low minimum inhibitory
`concentration (MIC) on Trichophyton rubrum or Trichophy-
`ton mentagrophytes. Trichophytosis is a parasitic mycosis in
`keratinous tissues such as the stratum corneum of skin, hair
`and nails. Parasitic nail mycosis (onychomycosis trichophyt-
`ica) is known as a particularly troublesome disease. Ony-
`chomycosis trichophytica has been treated mainly with oral
`antifungal medication.~’21 This oral therapy, however, some-
`times has severe systemic side-effects, such as liver dysfunc-
`tion,31 which interrupt the therapy. Although a lot of research
`has been published on the effect of clinical topical and sys-
`temic treatments of onychomycosis trichophytica, there are
`few in vitro nail plate penetration studies following topical
`drug exposure. Waiters et al.41 have suggested that the nail
`plate behaves like a hydrophilic gel membrane and that it has
`an additional lipophilic route from penetration data using ho-
`mologous alcohols. They also inferred that solvents such as
`dimethylsulphoxide and isopropyl alcohol, which tend to
`promote drug diffusion through the stratum corneum of skin,
`had little effect on nail plate permeation.5~
`Since few investigations have appeared regarding the en-
`hancement of nail plate permeation, we developed a modified
`side-by-side (2-chamber) diffusion cell to find out a penetra-
`tion-enhancing system.61 The barrier function of the nail
`plate may be closely related to changes in its physicochemi-
`cal properties (swelling and softening). The changes in the
`weight and stress of the nail pieces were then investigated.
`Urea and sodium salicylate are well known to have a keratin-
`softening effect and we previously reported that a new hy-
`drophilic multicomponent vehicle, consisting of l-menthol,
`ethanol and water (MEW system), markedly enhanced the
`in 71 permeation of morph e and several cardiovascular agentss)
`
`through hairless rat and human skin. We also reported that a
`
`new lipophilic multicomponent vehicle, consisting of L-lactic
`acid, ethanol and isopropyl myristate (LEI system), greatly
`promoted the skin permeation of ketotifen and several other
`drugs.9’1°1 In addition, chloramphenicol permeation from
`lipophilic vehicles or nail lacquers through the human nail
`plate or hoof membrane was compared with that from aque-
`ous systems. ~ l ) Also, a clinical trial showed that N-acetyl-L-
`cysteine (AC) increased oxiconazole levels in the nailJ21
`Therefore, keratin-softening agents (urea and sodium salicy-
`late), new skin permeation enhancers (MEW and LEI sys-
`tems) and agents reducing the disulfide linkages in hard ker-
`atin (AC and 2-mercaptoethanol) were selected as additives
`for evaluation. Tolnaftate (TN) and 5-fluorouracil (5-FU)
`were used as lipophilic and hydrophilic model drugs, respec-
`tively.
`
`Experimental
`Materials TN was supplied by Nissan Chemical Co., Ltd. (Tokyo,
`Japan). 5-FU and IPM were obtained from Tokyo Kasei Kogyo Co., Ltd.
`(Tokyo, Japan). Urea, sodium salicylate, L-lactic acid, ethanol, AC and 2-
`mercaptoethanol (ME) were obtained from Wako Pure Chemical Industries,
`Ltd. (Osaka, Japan). 1-Menthol was supplied by Toko Pharmaceutical Ind.
`Co., Ltd. (Tokyo, Japan). Other reagents were from commercial sources.
`Preparation of the Nail Plate Tip nail pieces (8--25mg) were ob-
`tained from the fingers of healthy volunteers (9 males; mean age 24 years,
`range 21 -32) using nail clippers. Nail pieces, which had been allowed to
`grow for at least one month, were used in this study. Nine or seven nail
`pieces were obtained from the 5th finger of each volunteer, hydrated for a
`day and then used to compare the nail permeation from each solvent system.
`Nail pieces from the 2nd, 3rd and 4th fingers were used to measure physico-
`chemical properties.
`Solubilities and Partition Coefficients 5-FU- or TN-vehicle suspen-
`sions were mixed by a magnetic stirrer at 37 °C. After 24h each suspension
`underwent filtration (Ekicrodisc 3 or 3CR; German Sciences Japan, Ltd.,
`Tokyo). The filtrate was immediately diluted with methanol or acetonitrile to
`obtain samples for analysis. The octanol/vehicle partition coefficient of the
`drugs (Ko~) was defined as the solubility ratio in octanol/vehicle at 37 °C.
`Measurement of Physicochemical Properties of Nail Pieces The
`
`* To whom correspondence should be addressed.
`
`’~, 1998 Pharmaceutical Society of Japan
`
`NII-Electronic Library Service
`
`ARGENTUM EX1024
`
`Page 1
`
`

`

`Vol. 46, No. 11
`
`system (LC-6A, Shimadzu Seisakusho, Kyoto), an UV detector (SPD-6A,
`Shimadzu), a chromatopack (C-R6A, Shimadzu), a system controller (SCL-
`6B, Shimadzu), an auto injector (SIL-6B, Shimadzu) , and a reverse phase
`column (lnertsil ODS 250mmX4.6mm i.d., GL Sciences Inc., Tokyo). The
`mobile phase used tbr measuring TN was water : methanol (3 : 7) at a flow
`rate of 1 ml/min, and detection at ,t.=260nm. The mobile phase for 5-FU
`was 0.l% phosphoric acid:acctonitrile (98 : 2) at a flow rate of 1 ml/min, and
`detection at ,%-270 nm.
`
`Results and Discussion
`Effect of Each Vehicle on the Physicochemical Proper-
`ties of the Nail Plate Table 1 summarizes the composition
`of the various solvent systems and the solubility of 5-FU and
`TN in the solvent systems used in these experiments. The ef-
`fect of each vehicle on the physicochemical properties
`(swelling and softening) of the nail plate was studied to com-
`pare the drug permeation from each vehicle through each
`human nail plate. Water was selected as a control vehicle.
`Figure 4 shows the weight and stress ratios (WEst~p21/
`W[stcp[] and S[Step2]/S[stepl]) 6d after immersion of the nail
`pieces in several solvent systems. In comparison with non-
`treated nail pieces, the nail piece weight ratio of the control
`
`Synchronous motor
`
`Star-head bar
`
`N
`
`Cell adapter
`
`Water jacket
`
`Nail piece
`
`O-Shaped ring
`
`Fig. 2. Schematic Diagram of the Modified Side-by-Side Diffusion Cell
`
`Step 1
`with5-FU
`
`Time (day) ~ 0
`
`I
`
`Step 2
`Step 3
`! i withS-FU I I with5-FU
`II
`II
`
`4
`I
`
`23
`
`7 8
`15 16
`washout
`washout
`Treatment -------I~- I I I t I I
`water water
`0,0.1,0.5, 1,3, 5, or
`10 % AC solution
`
`1798
`
`weights and stresses of the finger nail pieces from healthy volunteers were
`measured before treatment (day 0) (Step 1). Each nail piece was immersed
`in 10ml of each vehicle at 37 °C, and was subsequently measured on day 6
`(Step 2). In the investigation to measure the effect of AC concentration on
`the physicoehemical properties of the nail plate, each nail piece was im-
`mersed in 10 ml water for another 6 days to check the reversibility (Step 3).
`Alter this nail piece was wiped by Kimwipes® and weighed by an electronic
`balance (JL-200, Cbyo Balance Corp.). The bending stress of each nail piece
`was measured by a rheometer (NMR-2000J, Fudo Kogyo Co., Ltd.) with an
`attachment guide (Fig. 1).13) The resulting stress (Sistepz or 31) and weight
`(W[srep2 or 31) product of each treated nail piece and its respective untreated
`nail piece (Srstepll’W[stepll) were used as an index for nail softening and
`swelling (Scstep2 or 3l/Srstepl], W[step2 or 3j/W[slcpl])’
`Permeation Studies A piece of nail plate was sandwiched between 2
`adapters made of polypropylene with an O-shaped ring (effective diffusion
`area, 0.049cm2) and mounted in a side-by-side (2-chamber) diffusion cell
`with a water-jacket connected to a water-bath at 37°C (Fig. 2). The dorsal
`nail plate side was filled with 2.5ml drug suspension in each solution, and
`the ventral nail plate side with the same volume of water or 40% polyethyl-
`ene glycol 400. No preservative was added because the receiver solution was
`clear even at the end of the experiment. The drug permeation was measured
`by sampling the ventral nail plate side solution at predetermined times. The
`experimental period was 7 d (5-FU) or 18 d (TN), because of the low nail
`permeability of the drugs. To overcome the large variation in nail permeabil-
`ities due to individual differences in the barrier properties, two experimental
`schedules were maintained: (i) use of nail pieces from the same finger of the
`same volunteer and (ii) continuous use of the same nail piece. The effect of
`different concentrations of AC (0, 0.1, 0.5, 1, 3, 5, 10%) on the in vitro nail
`permeation of 5-FU was investigated according to the experimental schedule
`shown in Fig. 3.
`Analytical Methods 5-FU and TN were determined by HPLC. The ab-
`solute calibration method was applied for 5-FU. The sample containing TN
`was added to a methanol solution containing dipbenyl phthalate as an inter-
`nal standard. The solution was injected into an HPLC consisting of a pump
`
`Load Cell
`
`Nail piece
`
`Guide
`
`Nail piece
`under st,’ess
`
`Fig. 1.
`
`Measurement of Stress on Nail Pieces
`
`8mm
`
`Table 1.
`
`Solubilities of 5-FU and TN in Each Solution
`
`Fig. 3. Experimental Schedule (ii) for the Nail Plate Permeation Study
`
`Composition of solvent systems
`
`5-FU (rag/rot)
`
`TN (pg/ml)
`
`Water
`MEW (3% 1-menthol-40% ethanol water)
`AEW (3% acetylcysteine-40% ethanol water)
`MEEW (3% mercaptoethanolM0% ethanol-water)
`LEI (1% lactic aci~l 0% ethanol-isopropyl myristate)
`AEI (0.5% acetylcysteine-10% ethanol isopropyl myristate)
`MEEI (3% mercaptoethanol-10% ethanol-isopropyt myristate)
`Urea (8 M urea)
`Na salicylate (40% sodium salicylate)
`
`17.1
`19.6
`20.2
`24.6
`0.228
`0.528
`0.266
`5.11
`38.4
`
`0.391
`373.8
`118.1
`107.1
`29610
`24681
`28009
`0.853
`39.82
`
`NII-Electronic Library Service
`
`Page 2
`
`

`

`November 1998 1799
`
`a)
`
`Non-treatment
`
`MEW
`
`AEW
`
`MEEW
`
`LEI
`
`AEI
`
`MEEI
`
`Urea
`
`b)
`
`Non-treatment
`
`Water
`
`MEW __
`
`AEW ¯
`
`MEEW
`
`LEI
`
`AEI
`
`MEEI -
`
`Urea "__
`
`J
`~////AV i
`
`Na Salicylate
`
`Na Salieylate
`
`0.0 0.5
`
`1.0 1.5 2.0 2.5
`
`3.0
`
`3.5 4.0
`
`|
`0.4 0.6 0.8 1.0 1.2 1.4 1.6
`
`0.0 0.2
`
`Weight ratio
`
`Stress ratio
`
`Fig. 4.
`
`Weight and Stress Ratio 6 days after Treatment with Several Solvent Systems
`
`Each value represents the mean+-S.E. (n=6).
`
`vehicle (water) was increased by about 0.2points and its
`stress ratio was decreased by about 0.7points. In addition,
`the nail piece weight was increased and its stress was de-
`creased in water-containing solvent systems. Compared with
`the water control, 8 M urea (Urea) and 40% sodium salicylate
`(Na salicylate) increased the nail piece weight ratio by
`0.25--0.47 points and lowered the nail piece stress ratio by
`0.06--0.10 points. In contrast, the MEW system had approx-
`imately the same nail weight and stress ratio as those of the
`control vehicle. AEW (3% acetylcysteine-40% ethanol-
`water) and MEEW (3% mercaptoethanol-40% ethanol-
`water) systems containing agents reducing the disulfide link-
`ages increased the nail weight ratio by 2.45 and 0.45 points,
`respectively. The AEW and MEEW systems decreased the
`nail stress ratio by about 0.915 and 0.926 points, respectively.
`In contrast with the non-treated nail pieces, the LEI system, a
`water free system, had little effect on the weight and stress
`ratio of each nail piece. Although the AEI (0.5% acetylcys-
`teine-10% ethanol-isopropyl myristate) and MEEI (3% mer-
`captoethanol-10% ethanol-isopropyl myristate) systems also
`had little effect on nail swelling and softening, AC and ME in
`aqueous solvent systems had a significant effect. These re-
`sults suggest that water may physically change the nail plate
`keratin. In addition, urea, sodium salicylate, AC and ME in
`aqueous solvent systems may denature the nail keratin,
`whereas this denaturation may not take place in water-fi’ee
`solvents. Urea and ME can be used to extract keratin from
`nails or wool.l<lS~ Therefore, those additives are likely to in-
`crease drug permeation through the human nail plate.
`Effect of Each Vehicle on Drug Permeation through the
`Nail Plate The steady-state flux (J) of drugs through the
`human nail plate can be represented by Fick’s first law of dif-
`fusion, as follows:
`
`J=D. K,,,,. CJL
`
`(1)
`
`where D, KN/,,, Cv and L are the diffusion coefficient in the
`human nail plate, the human nail plate/vehicle partition coef-
`ficient, the concentration in the donor vehicle of the drug and
`the thickness of the human nail plate, respectively. The per-
`meability coefficient (P) is represented by
`
`Table 2. Effect of Several Solvent Systems on the Flux of 5-FU and TN
`through the Human Nail Plate
`
`Solvent system
`
`5-FU (pg/cm2/h)
`
`TN (yg/cm2/h)
`
`Water
`MEW
`AEW
`MEEW
`LEI
`AEI
`MEEI
`Urea
`Na salicylate
`
`17.4+-4.3
`16.3_+3.3
`
`228.8_+52.3
`275.1 4-125.8
`20.5_+5.2
`116.4_+6.8
`146.8--_23
`3.7_+0.2
`6.6_+0.3
`
`N,D.~)
`N.D.
`0.137-+0.080
`0.058+0.017
`N.D.
`0.053 -+0.009
`0.223_+0.032
`N.D.
`N.D.
`
`a) Not determined. Each value represents the mean+-S.E. (n=3).
`
`P= (D. KN,~)!L
`
`(2)
`
`In the present study, both TN and 5-FU were suspended in
`all the donor vehicles. Therefore, their thermodynamic activ-
`ities in each donor vehicle are at a maximum and the same
`value. In the case of equal diffusion coefficients or equal ac-
`tivity coefficients, it is thought that the permeation fluxes of
`the drugs from each vehicle are the same. On the other hand,
`the permeability coefficient reflects the activity coefficient of
`the drugs in the human nail plate and the change in their sol-
`ubility in vehicle. Thus, it is possible to evaluate drug diffu-
`sion in the membrane and drug partition to the membrane.
`Table 2 shows the steady-state flux of TN and 5-FU from
`several solvent systems through the human nail plate. The 5-
`FU flux from the MEW system was not increased, in com-
`parison with that from the water (control) vehicle. In spite of
`other changes in the physicochemical properties of the nail
`plate, aqueous solvent systems containing keratin-softening
`agents (urea and Na salicylate) decreased the 5-FU flux. The
`LEI system (a lipophilic system) slightly enhanced the per-
`meation of 5-FU through the human nail plate. It has been
`reported that the dissociation of benzoic acid and pyridine
`leads to a reduction in their penetration rate through hoof
`membrane.16) When an acidic drug, 5-FU (pK, = 8.0, 13.0), is
`suspended in aqueous solutions of keratin-softening agents
`(urea: pH=7.2, Na salicylate: pH=6.2), the pH in the nail
`plate would be shifted to a more basic value, compared with
`
`NII-Electronic Library Service
`
`Page 3
`
`

`

`1800 Vol. 46, No. I 1
`
`a) 5-FU
`
`b) TN
`
`AEI
`MEEI ¯
`
`LEI
`I
`
`-3
`
`-4
`
`-5
`
`-6
`
`-7
`
`ta
`
`AEW
`
`MEEW
`
`Water
`
`MEW ~ Urea¯
`
`-5
`
`-6
`
`-7
`
`-8
`
`MEEI
`
`-9
`
`AEI
`
`AEW
`
`MEEW
`
`Na sallcylate

`
`i -
`-1
`
`-8
`-2
`
`/ i ¯
`0
`1
`
`i
`2
`
`-10
`-1
`

`
`i ¯
`
`i ¯
`
`o
`
`1
`
`i
`
`2
`
`Log Kov
`
`Log Kov
`
`Fig. 5. Relationship between log K~ and log P of 5-FU and TN
`
`Each value represents the mean+S.E. (n :3).
`
`a)
`
`b)
`
`0,4
`
`0.3
`
`0.2
`
`o.1
`
`.9
`
`I.
`
`t
`
`5
`
`4
`
`3
`
`2
`
`z=
`
`1’
`

`
`0
`
`0
`
`i , i -
`i . i ¯
`i ¯
`i
`2 4 6 8 10 12
`AC conc. (%)
`
`0.0
`

`
`i , p , i , i ¯
`i ¯
`i
`2 4 6 8 10 12
`AC conc. (%)
`
`Fig. 6. Weight and Stress Ratio 6 d after Treatment with a Variety of AC Concentrations
`
`O: Step2!Stepl, A: Step3iStepl. Each value represents the mean_+S.E. (n=6).
`
`that of the control vehicle (pH=4.7). In contrast, the pH
`would be lowered by L-lactic acid in the LEI system. There-
`fore, a pH change in the nail plate can account for these ob-
`servations. A combination with urea effectively increased bi-
`fonazole penetration into the nail plate in clinical trials.]7/If
`the penetrant is a basic drug, such as bifonazole, then urea
`and sodium salicylate may exhibit increased permeation
`through the nail plate.
`On the other hand, aqueous solvent systems (AEW or
`MEEW systems) containing AC or ME had about 13 and 16
`times higher 5-FU fluxes than those obtained in the control
`vehicle. In addition, lipophilic systems (AEI and MEEI sys-
`tems) containing AC or ME had about 6.7 and 8.4 times
`higher 5-FU fluxes than in the control, respectively. Only the
`permeation of TN from AEW, MEEW, AEI and MEEI sys-
`tems could be measured, while that from other solvent sys-
`tems was undetectable. It was assumed that TN had a low
`nail permeation because of its high molecular weight and low
`solubility in water, compared with 5-FU. The TN flux levels,
`through the human nail plate from several solvent systems
`containing AC or ME, exhibited the following pattern:
`AEI<MEEW<AEW<MEEI. AC and ME also increased the
`permeation flux of TN through the nail plate.
`
`The octanol/vehicle partition coefficient (Ko~) has been
`used extensively as an index of biological membrane!vehicle
`partition. We thus examined the relationship between the log-
`arithm of the octanol/vehicle partition coefficient tbr TN and
`5-FU and the logarithm of the permeability coefficient (Fig.
`5). TN showed high permeability coefficients from aqueous
`solvent systems, whereas 5-FU had high values from
`lipophilic systems. Solvent systems containing AC or ME in-
`creased the permeability of 5-FU and TN, but they were not
`dependent on log Kov. The lipid content in the human nail
`plate is much lower than that in the stratum cornetan of
`skin.Is’j9) Lipophilic additives such as I-menthol and iso-
`propyl myristate, which increase the skin permeation of
`drugs, had no effect on drug permeation through the nail
`plate. Ethanol was not able to promote drug diffusion
`through the nail plate, which agrees with the findings of Wal-
`ters et al.5) The nail plate of a healthy volunteer is usually hy-
`drated and the water vapor loss normally amounts to about
`1.6 mg!cm2/h.2°) If the nail plate has swelled as is the case in
`vitro, a hydrophilic drug such as 5-FU would require a
`lipophilic vehicle to retain the high thermodynamic activity
`of the drug. Consequently, aqueous solvent systems are
`found to be best for lipophilic drugs like TN.
`
`NII-Electronic Library Service
`
`Page 4
`
`

`

`November 1998
`
`Effect of AC Concentration The effect of different con-
`centrations of AC on the physicochemical properties of nail
`pieces and the nail plate permeation of 5-FU (Step 2/Step 1)
`were investigated in more detail. The reversibility of any
`changes was also tested (Step 3!Step 1). The flux ratio for
`Step 2/Step 1 was used as an index for the enhancing effect
`of AC, and the flux ratio for Step 3/Step 1 was used as an
`index for the disappearance of the enhancing effect of AC.
`Figure 6 shows the weight and stress ratio of nail pieces on
`day 6 (Step 2/Step l) and day 12 (Step 3/Step 1) at each con-
`centration of AC. The weight and stress ratio of nail pieces
`increased and decreased, respectively, with increasing AC
`concentration. In high concentrations of AC, the weight ratio
`of nail pieces increased marginally. A marked effect on the
`stress ratio of nail pieces was found at low concentrations of
`AC. Although low reversibility was observed for the physico-
`chemical changes in nail pieces, the weight and stress ratio of
`the nail, were not similar to those of the control (water).
`Figm’e 7 shows the permeation flux ratio of 5-FU through
`the nail plate from vehicles containing different concentra-
`tions of AC, for each step. The flux ratio of 5-FU for Step
`2/Step 1 increased with an increase in AC concentration. The
`Step 3/Step 1 ratios were similar to the Step 2/Step 1 ratios,
`although they were a little lower than the Step 2/Step 1 ratios,
`especially at high concentrations, suggesting low reversibility
`
`20
`
`15
`
`10
`
`@
`
`i
`

`
`0 .
`0
`
`i
`2
`
`i . i
`i . i -
`i ¯
`4 6 8 10 12
`AC cone. (%)
`
`1801
`
`of the enhancing effect by AC. A long period may be neces-
`sary until the barrier function of the nail plate recovers. In
`3% AC, water flux was about 3 times higher than that of the
`control (data not shown), showing that AC increased drug
`diffusion across the nail plate.
`Figure 8 shows the relationships between the nail weight
`or stress ratio and the flux ratio of 5-FU. The flux ratio in-
`creased with an increase in the weight ratio and a decrease in
`the stress ratio. This suggests that the penetration-enhancing
`effect of 5-FU by AC is closely depending on the swelling
`and softening of the nail pieces. A marked swelling and soft-
`ening of the nail plate takes place, presumably due to cleav-
`age of S S bonds in the nail plate. As a result, the barrier to
`drug permeation across the nail plate is low.
`A lot of cystines, having stable disulfide linkages, are pre-
`sent in human keratinized nail plate.2u Since cysteine has a
`reducing action on cystine in the human nail plate, AC may
`cleave the S-S bonds in keratin. Cleavage of these bonds
`may be associated with the increase in weight and decrease
`in stress of the nail pieces. In addition, drug permeation
`through the human nail plate may also be enhanced as a re-
`sult of increased diffusion through the affected keratinized
`nail plate.
`
`Conclusion
`The penetration of 5-FU and TN through the human nail
`plate was studied in vitro. A penetration-enhancing effect
`was observed in all solvent systems containing AC or ME.
`The permeation flux of 5-FU was directly proportional to the
`AC concentration. However, the reversibility of the nail plate
`barrier function was insignificant. The penetration-enhancing
`effect by AC was closely dependent on the swelling and soft-
`ening of the nail plate. AC and ME cleave the S-S bond in
`the hard keratin in human nail plate. Such additives are thus
`able to enhance drug permeation through the human nail
`plate.
`
`Acknowledgments The authors wish to thank volunteers at Josai Uni-
`versity tor supplying nail pieces.
`
`Fig. 7. Enhancing Effect of Various AC Concentrations on the Nail Plate
`Permeation of 5-FU
`0: Step2/Stepl, A: Step3/Stepl. Each value represents the mean-+S.E. (n=3).
`
`References
`1) Piepponen T., Blomqvist K., Brandt H.~ Havu V., Hollmen A., Ko-
`htamfiki K., Lehtonen L., Turjanmaa K., J Antimicrobial Chemother-
`a!~y, 29, 195.--205 (1992).
`
`a)
`
`20
`
`15
`
`lO
`
`o
`
`b)
`
`20
`
`15
`
`.i
`
`$
`
`,
`
`i , i i
`2 3 4
`Weight ratio
`
`0,0
`
`o.’1
`
`0.4
`
`Stress ratio
`
`Fig. 8. Relationship between the Weight Ratio (a) or the Stress Ratio (b) and the Flux Ratio of 5-FU
`
`O: Step2/Stepl, A: Step3/Stepl. Each value represents the mean±S.E. (n=3 6).
`
`NII-Electronic Library Service
`
`Page 5
`
`

`

`1802
`
`Vol. 46, No. 11
`
`2) Villars V. V, Jones T. C., Br. J Derm., 126 (Suppl. 39), 61~9 (I992).
`3) Wilson J. W., Plunkett O. A., Univ. Calif. Press, Berkeley, 1962, pp.
`231--251.
`4) Waiters K. A, Flynn G. L., Marvel J. R., J. Pharm. Pharmacol., 35,
`28 33 (1983).
`5) Wakers K. A., Flynn G. L., Marvel J. R., J Pharm. Pharmacol., 37,
`771--775 (1985).
`6) Okumura M., Nakamori Y., Yoshida Y., Drug Des. Del., 6, 137 148
`(1990).
`7) Morimoto Y., Sugibayashi K., Kobayashi D., Shoji H., Yamazaki J.,
`Kimura M., Int. J Pharm., 91, 9--14 (1993).
`8) Kobayashi D., Matsuzawa T., Sugibayashi K., Morimoto Y., Kobayashi
`M., Kimura M., Biol. Pharm. Bull., 16, 254--258 (1993).
`9) Nakamura H., Pongpaibul Y., Hayashi T., Sugibayashi K., Morimoto
`Y., Int. J Pharm., 141, 71--80 (1996).
`10) Nakamura H., Kobayashi Y., Sugibayashi K., Morimoto Y., Drug De-
`lively System, 12, 101 106 (1997).
`
`I 1) Mertin D., Lippold B. C., J Pharm. Pharmacol., 49, 241--245 (1997).
`12) Hoogdalem E. J., Hoven W E., Terpstra I. J., Zijtveld J., Verschoor J.
`S. C., Visser J. N, Era: J. Pharm. Sci., 5, 119-- 127 (1997).
`13) Yamazaki K., Tanaka M., J Soc. (-bsmet. Chem. Japan, 25, 144~ 161
`(1991).
`14) Kitahara T., Ogawa H., J DermatologicalSci., 2, 402406 (1991).
`15) 5Zamauchi K., FragranceJ., 5, 62--67 (1993).
`16) Mertin D., Lippold B. C., J Pharm. Pharmacol., 49, 30--34 (1997).
`17) Fritsch H., Stettendorf S., Hegemann L., Dermatology, 185, 32--36
`(1992).
`18) Waiters K. A., Flynn G. L., lnt..Z Cos. Sci., 5, 231--246 (1983).
`19) Hirose T., Momota H., Kitajima T., Okura S., Matsuda T., Motoyoshi
`K.,J Soc. Cosmet. Chem. Japan, 24, 98--105 (1990).
`20) Spruit D., Am. Perf. & Costa., 87, 57--58 (1972).
`21) Spearman R. 1. C., "The Physiology of the Nail," Vol. 5, ed. by Jarrett
`A., Academic Press, London, 1978, pp. 1810--1855.
`
`NII-Electronic Library Service
`
`Page 6
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket